Julian Baker’s PHAXIAM Therapeutics S.A.. American Depositary Shares PHXM Stock Holding History

Julian Baker’s Portfolio PHXM Stock Details PHXM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-108,597	Closed	-$9.31M	–	97
2018 Q3	$9.31M	Sell	108,597 -200,000	-65%	-$20.8M	0.06%	53
2018 Q2	$34.5M	Sell	308,597 -410	-0.1%	-$77K	0.26%	30
2018 Q1	$64.9M	Hold	309,007	–	–	0.55%	24
2017 Q4	$68M	Buy	+309,007	New	+$73M	0.59%	19

Other funds holding PHXM

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

SFM

Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return

Delek Group Herzliya, Israel $2.59B AUM 1.24% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Julian Baker's PHXM Position: Q4 2018 in Review

Julian Baker sold out of PHAXIAM Therapeutics S.A.. American Depositary Shares (PHXM) in Q4 2018, closing a stake of 108,597 shares — an estimated $9.31M sold.

Julian Baker first reported a position in PHXM in Q4 2017 and held it in 4 quarters. The position peaked at $68M in Q4 2017. 5 funds tracked by Wall St. Rank hold PHXM as of Q4 2018.

Julian Baker reported no remaining PHAXIAM Therapeutics S.A.. American Depositary Shares position as of Q4 2018 after selling out during the quarter.
Julian Baker sold 108,597 PHAXIAM Therapeutics S.A.. American Depositary Shares shares in Q4 2018, an estimated $9.31M.
Julian Baker first reported a position in PHAXIAM Therapeutics S.A.. American Depositary Shares in Q4 2017 and held it in 4 quarters.
Julian Baker's PHAXIAM Therapeutics S.A.. American Depositary Shares position peaked at $68M in Q4 2017.
5 funds tracked by Wall St. Rank held PHAXIAM Therapeutics S.A.. American Depositary Shares as of Q4 2018.

Based on Baker Bros. Advisors's 13F filing for Q4 2018, filed 13 Feb 2019.